| P2093 | author name string | Julian F Guest | |
| | Mark J Greener | |
| P2860 | cites work | Depression and public health | Q29999595 |
| | A systematic review of the mortality of depression | Q33534388 |
| | Selective serotonin reuptake inhibitors. Assessment for formulary inclusion | Q33572105 |
| | A community study of depression treatment and employment earnings | Q33729524 |
| | Are all antidepressants the same? | Q33896409 |
| | Depression in the workplace. Impact on employees. | Q33949379 |
| | Safety and tolerability considerations: tricyclic antidepressants vs. selective serotonin reuptake inhibitors. | Q34053639 |
| | Sleep disturbances and mood disorders: an epidemiologic perspective | Q34378474 |
| | Treatment non-adherence in affective disorders. | Q34592227 |
| | The business case for quality mental health services: why employers should care about the mental health and well-being of their employees | Q34615135 |
| | Depression predicts disability in long-term chronic pain patients. | Q34643739 |
| | The impact of treatment-resistant depression on health care utilization and costs | Q35005637 |
| | Coping with somatic comorbidities: striving for complete recovery. | Q35029957 |
| | A psychosocial understanding of depression in women: for the primary care physician | Q35881346 |
| | Daytime sleepiness and insomnia as correlates of depression. | Q35969989 |
| | A comparison of depression and physical illness in men and women | Q38578866 |
| | The economic evaluation of depression | Q40506305 |
| | Depression in the workplace: effects on short-term disability | Q40796640 |
| | The economic burden of depression in 1990. | Q41062920 |
| | Effect of primary care treatment of depression on service use by patients with high medical expenditures | Q42654113 |
| | Depression in the workplace: negative effects, perspective on drug costs and benefit solutions. | Q43616855 |
| | Recovery from depression, work productivity, and health care costs among primary care patients | Q43889076 |
| | Prevalence, burden, and treatment of insomnia in primary care | Q44196979 |
| | Enhancing adherence to prevent depression relapse in primary care | Q44583683 |
| | Depression and chronic fatigue in the workplace. Workers' compensation and occupational issues | Q46028388 |
| | Sleep disturbances and chronic disease in older adults: results of the 2003 National Sleep Foundation Sleep in America Survey | Q47975162 |
| | Effects of fluvoxamine and dothiepin on psychomotor abilities in healthy volunteers | Q49126870 |
| | The impact of psychiatric disorders on work loss days | Q50181458 |
| | [Prevalence and risk factors of suicide and attempted suicide] | Q50598016 |
| | Depression: a neglected major illness. | Q50605674 |
| | Earnings changes for depressed individuals treated by mental health specialists. | Q50637431 |
| | Cost of lost productive work time among US workers with depression. | Q50721123 |
| | Rationalization as a key stressor for public sector employees: an organizational case study. | Q51097309 |
| | Depressive symptoms, satisfaction with health care, and 2-year work outcomes in an employed population. | Q51967275 |
| | The quality of care for depressive and anxiety disorders in the United States. | Q51970557 |
| | Predicting factors for absenteeism in patients with major depressive disorders. | Q52005217 |
| | Treatments of depression and the functional capacity to work. | Q52478123 |
| | Subclinical depression and performance at work | Q57221937 |
| | Depression, disability days, and days lost from work in a prospective epidemiologic survey | Q68431337 |
| | The functioning and well-being of depressed patients. Results from the Medical Outcomes Study | Q69667941 |
| | The costs of treating depression | Q72680600 |
| | Impact of fluoxetine on work loss in depression | Q72695761 |
| | [Work loss and depression. Impact of fluoxetine] | Q72880020 |
| | Influence of socio-economic deprivation on the prevalence and outcome of depression in primary care: the Hampshire Depression Project | Q73340982 |
| | Depression in the community: the first pan-European study DEPRES (Depression Research in European Society) | Q73406200 |
| | Depression in the workforce: seeing the cost in a fuller light | Q74069497 |
| | Effects of efforts to increase response rates on a workplace chronic condition screening survey | Q74757078 |
| | The Cardiff sib-pair study: suicidal ideation in depressed and healthy subjects and their siblings | Q77305895 |
| | Depression in the workplace: economics and interventions | Q77500714 |
| | Depression's surprising toll on worker productivity | Q77672685 |
| | A general model of the impact of absenteeism on employers and employees | Q77841294 |
| P433 | issue | 3 | |
| P1104 | number of pages | 12 | |
| P304 | page(s) | 253-264 | |
| P577 | publication date | 2005-01-01 | |
| P1433 | published in | CNS Drugs | Q5013183 |
| P1476 | title | Do antidepressants reduce the burden imposed by depression on employers? | |
| P478 | volume | 19 | |